Twin Tree Management
FSTX

Twin Tree Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Twin Tree Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-94
Closed -$4K – 1668
2018
Q4 		$4K Buy
+94
New +$4.23K ﹤0.01% 1224

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Twin Tree Management's FSTX Position: Q1 2019 in Review

Twin Tree Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2019, closing a stake of 94 shares — an estimated $4K sold.

Twin Tree Management first reported a position in FSTX in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 54 funds tracked by Wall St. Rank hold FSTX as of Q1 2019.

  • Twin Tree Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Twin Tree Management sold 94 F-star Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $4K.
  • Twin Tree Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Twin Tree Management's F-star Therapeutics, Inc. Common Stock position peaked at $4K in Q4 2018.
  • 54 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Twin Tree Management's 13F filing for Q1 2019, filed 10 May 2019.